Zylox-Tonbridge Medical Technology Co (HKSE:02190) Change In Receivables : HK$0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Change In Receivables?

Zylox-Tonbridge Medical Technology Co's change in receivables for the quarter that ended in Dec. 2024 was HK$0.0 Mil. It means Zylox-Tonbridge Medical Technology Co's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Zylox-Tonbridge Medical Technology Co's change in receivables for the fiscal year that ended in Dec. 2024 was HK$-0.4 Mil. It means Zylox-Tonbridge Medical Technology Co's Accounts Receivable increased by HK$0.4 Mil from Dec. 2023 to Dec. 2024 .

Zylox-Tonbridge Medical Technology Co's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$1.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 0.67.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zylox-Tonbridge Medical Technology Co's liquidation value for the six months ended in Dec. 2024 was HK$1,105.3 Mil.

Zylox-Tonbridge Medical Technology Co Change In Receivables Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Change In Receivables Chart

Zylox-Tonbridge Medical Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

1.05

-0.40

-0.64

-0.19

-0.38

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial						-	-	-	-	-

Zylox-Tonbridge Medical Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zylox-Tonbridge Medical Technology Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.643	/	444.67	*	91
=	0.67

2. In Ben Graham's calculation of liquidation value, Zylox-Tonbridge Medical Technology Co's accounts receivable are only considered to be worth 75% of book value:

Zylox-Tonbridge Medical Technology Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1369.706	-	375.347	+	0.75 * 1.643	+	0.5 * 219.381
=	1,105.3

Zylox-Tonbridge Medical Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).

Executives

Wea Enterprises, Llc	2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhong Shengping Sam	2401 A concert party to an agreement to buy shares
Zhao Jonathon Zhong	2501 Other
Wei Na	2501 Other
Li Zheng	2501 Other
Wang Stephen Hui	2201 Interest of corporation controlled by you
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Schroders Plc	2102 Investment manager
Highlight Medical Limited	2501 Other
Ourea Biotech Hk Limited	2501 Other

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines